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Abstract
The role of hydrogen sulfide (H2S) in inflammation is controversial, with both pro- and antiinflammatory effects
documented. Many studies have used simple sulfide salts as the source of H2S, which give a rapid bolus of H2S
in aqueous solutions and thus do not accurately reflect the enzymatic generation of H2S. We therefore compared
the effects of sodium hydrosulfide and a novel slow-releasing H2S donor (GYY4137) on the release of pro- and
antiinflammatory mediators in lipopolysaccharide (LPS)-treated murine RAW264.7 macrophages. For the first
time, we show that GYY4137 significantly and concentration-dependently inhibits LPS-induced release of
proinflammatory mediators such as IL-1b, IL-6, TNF-a, nitric oxide (NO), and PGE2 but increased the synthesis
of the antiinflammatory chemokine IL-10 through NF-kB=ATF-2=HSP-27–dependent pathways. In contrast,
NaHS elicited a biphasic effect on proinflammatory mediators and, at high concentrations, increased the syn-
thesis of IL-1b, IL-6, NO, PGE2 and TNF-a. This study clearly shows that the effects of H2S on the inflammatory
process are complex and dependent not only on H2S concentration but also on the rate of H2S generation. This
study may also explain some of the apparent discrepancies in the literature regarding the pro- versus antiin-
flammatory role of H2S. Antioxid. Redox Signal. 12, 1147–1154.
Introduction
Hydrogen sulfide (H2S) is a pungent gas that is formedendogenously in mammalian tissues from the amino
acids cysteine and homocysteine by pyridoxal-50-phosphate–
dependent enzymes such as cystathionine-g-lyase (CSE; E.C.
4.4.1.1) and cystathionine-b-synthetase (CBS; E.C. 4.2.1.22)
(12, 28). To date, H2S biosynthesis has been identified in a
variety of mammalian tissues, notably in the brain, heart, and
the gastrointestinal tract, as well as in isolated vascular
smooth muscle and endothelial cells and neurons (19, 29). A
number of possible physiologic and pathophysiologic roles
for this gas have been put forward, and a range of potential
therapeutic uses of this gas has been proposed (10, 21, 28).
It is now becoming increasingly apparent that H2S exerts
complex effects on inflammation. For example, we previously
reported that administration of sodium hydrosulfide (NaHS),
a ‘‘fast releasing’’ H2S donor, to mice (9) provokes an in-
flammatory reaction, as evidenced by increased liver and lung
myeloperoxidase (MPO) activity (a marker for tissue leuko-
cyte infiltration) and histologically by the presence of accu-
mulated leukocytes extravascularly in the lung. These results
suggest a proinflammatory effect of H2S, as does the finding
that dl-propargylglycine (PAG), an irreversible inhibitor of
CSE, exhibits antiinflammatory activity in a range of animal
models of inflammation (2, 4, 14).
However, NaHS also has been reported to inhibit leukocyte
adhesion to gastric mucosal blood vessels (30), which may be
suggestive of an antiinflammatory effect. In addition, H2S
‘‘scavenges’’ proinflammatory oxidants such nitric oxide
(NO), peroxynitrite (ONOO-), hypochlorous acid (HOCl)
(25, 26), superoxide, and hydrogen peroxide (3, 6, 15); such
effects might be expected to alleviate inflammation. Finally,
S-diclofenac (an H2S-releasing derivative of the nonsteroidal
antiinflammatory drug, diclofenac) exhibitsmore-pronounced
antiinflammatory activity in endotoxic shock (11) and against
carrageenan-induced hindpaw edema (18) in the rat than does
diclofenac. In each case, evidence has been presented that the
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augmented antiinflammatory action of this compound is sec-
ondary to the release of H2S from the parent molecule.
Recently, this group reported that GYY4137 [morpholin-4-
ium 4 methoxyphenyl(morpholino) phosphinodithioate] re-
leases H2S slowly over a period of hours both in vitro and after
injection in the rat in vivo (13). In addition, GYY4137 exhibits
antiinflammatory activity in vivo, as evidenced by a reduction
in the lipopolysaccharide (LPS)-induced increase in plasma
proinflammatory cytokines (TNF-a, IL-1b, IL-6), nitrite=nitrate,
C-reactive protein, and l-selectin in the conscious rat (12).
H2S exerts complex and, at times, opposing effects on in-
flammation in whole animals. One possible explanation for
these discrepant data may be the choice of H2S donor used in
these various studies. The available H2S donors release H2S at
different rates and therefore give rise to different concentra-
tions of the gas over different time periods. In the present
work, we therefore compared the effect on LPS-induced
proinflammatory enzyme=metabolite generation in cultured
RAW 264.7 macrophages of the fast-releasing H2S donor,
NaHS, and the slow-releasing H2S donor, GYY4137.
Materials and Methods
Culture of RAW 264.7 cells
The murine RAW 264.7 macrophage cell line was pur-
chased from the American Type Culture Collection (Rock-
ville, MD). RAW 264.7 cells were chosen for the present
experiments, as macrophages play an integral part in the
etiology of inflammation, and their response to LPS has been
intensively characterized. Cells were cultured in complete
Dulbecco’s Modified Eagle Medium (containing 10% vol=vol
fetal bovine serum, 100U=ml penicillin, and 100mg=ml
streptomycin, pH 7.4) at 378C in 5% CO2 until *70–80%
confluence. Cells (0.2106 cells=ml) were then cultured over-
night before the addition of either NaHS or GYY4137 (both
0–1,000mM) along with an appropriate volume of vehicle, as
well as LPS (1 mg=ml). After a further 24-h incubation period,
medium or cells or both were harvested and assayed, as de-
scribed later.
For some experiments, GYY4137 was prepared in aqueous
solution and left unstoppered at room temperature for 5 days.
Such ‘‘decomposed GYY4137’’ failed to release H2S on incu-
bation and was therefore used as a control to assess the role of
released H2S in the effect of GYY4137. To determine whether
H2S donors were cytotoxic in these cells, cellular viability
was assessed by using 3-(4,5-dimethyl-2-yl)-2,5-diphenylte-
trazolium bromide (MTT), as described (25).
Assay of CSE=CBS enzyme activity
and measurement of H2S
CSE and CBS recombinant protein (12.5 mg; Abnova Ltd,
Taiwan) were added to Tris-HCl buffer (100mM; pH 7.4;
258C) containing l-cysteine (10mM) and pyridoxal phosphate
(10 mM). H2S generation was detected by using a World Pre-
cision Instruments H2S-selective membrane and electrode
(ISO-H2S-2; 2mm, Sarasota, FL), with four-channel TBR4100-
416 radical detector equipped with a Lab-Trax-4 four-channel
data-acquisition system, as described previously (13). In
separate experiments, H2S generation from added NaHS
(1 mM) and GYY4137 (100 mM) in phosphate-buffered saline
(3ml; pH 7.4; 258C) also was determined for comparison.
Assay of nitrite, PGE2, H2S, IL-1b, TNF-a,
IL-6, and IL-10 in medium
Levels of nitrite (NO2
), PGE2, IL-1b, TNF-a, IL-6, and IL-10
were assayed in culture media. NO2
 was determined spec-
trophotometrically in aliquots of culture medium by using the
Griess reagent, as described elsewhere (17). H2S in culture
medium was measured spectrophotometrically by using the
methylene blue assay, as described previously (9). IL-1b, TNF-
a, IL-6, and IL-10 were assayed with ELISA, according to the
manufacturer’s instructions (R&D Systems, Inc., Minneapolis,
MN). PGE2 production was determined by using a PGE2
enzyme immunoassay kit according to the manufacturer’s
instructions (Cayman, Ann Arbor, MI).
Assay of NF-kB, HSP-27, and pATF-2 in cells
RAW 264.7 cells treated as described earlier were har-
vested, and the nuclear proteins extracted by using a nuclear
extraction kit (Panomics, Fremont, CA), as described previ-
ously (11, 27). The nuclear extracts (10–20 mg) were assayed in
duplicate for activity by using TransAM NF-kB p65 assay kit
(ActiveMotif, Carlsbad, CA), according to the manufacturer’s
instructions. Data are shown as relative light units (RLUs).
Phosphorylation of HSP-27 and ATF-2 was assayed quanti-
tatively by using Fast Activated Cell-based ELISA (FACE)
HSP27(S82) and ATF2 (T71) kits (Active Motif Europe, Rix-
ensart, Belgium), again according to the manufacturer’s in-
struction.
Chemicals and data analysis
GYY4137 was synthesised chemically by Dr. Choon-Hong
Tan (Department of Chemistry, National University of Sin-
gapore), as described previously (13). Analytic kits were
purchased from suppliers, as stated in the text. All drugs and
chemicals were obtained from Sigma Chemical Company
(Peele, U.K.). Data are show as mean SEM, with the number
of observations indicated in parentheses. Statistical analysis
was with one-way ANOVA followed by the post hoc Tukey
test. A p value of< 0.05 was taken to indicate a statistically
significant difference.
Results
Release of H2S from CSE=CBS, GYY4137,
and NaHS in vitro
Incubation of either recombinant CSE or CBS enzyme with
added l-cysteine and cofactor resulted in the time-dependent
formation of H2S (Fig. 1A). CSE produced more H2S than CBS
under these experimental conditions, with the amount gen-
erated still increasing at 180 s for both enzymes. Incubation of
GYY4137 in aqueous solution also resulted in the release of
similar amounts of H2S over a similar time frame (Fig. 1C). In
contrast, release of H2S from incubated NaHS was much
greater (*200-fold) and occurred over a much shorter time
period (Fig. 1B).
Effect of GYY4137 and NaHS on LPS-evoked PGE2
and NO2
 formation
As expected (17), treatment of RAW 264.7 cells with LPS
resulted in a significant increase in both PGE2 and NO2

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concentrations in the medium. Treatment of LPS-exposed
RAW 264.7 cells with GYY4137 (0–1,000 mM) resulted in a
concentration-dependent inhibition of the biosynthesis of
both PGE2 (Fig. 2A) and NO2
 (Fig. 2B), with half-maximal
inhibitory concentration (IC50) values of 210.9 4.5 and
127.2 32.4 mM (n¼ 5). Furthermore, similar treatment of
RAW 264.7 cells with GYY4137 (100 mM) resulted in a sig-
nificant increase in the concentration of H2S detected in the
culture medium after 24 h (29.2 1.8 mM, c.f. 1.6 0.7 mM;
n¼ 5; p< 0.05). Inhibition of LPS-evoked formation of both
PGE2 and NO2
 was >90% inhibition at the higher con-
centration (>500mM) of GYY4137 used. ‘‘Decomposed
GYY4137’’ did not significantly affect LPS-evoked formation
of either PGE2 or NO2
 ( p> 0.05). In contrast, the effect of
NaHS (0–1,000 mM) on LPS-evoked PGE2 formation in cul-
tured RAW 264.7 cells was seemingly biphasic, with modest
inhibition (*40% of control values) apparent at lower con-
centrations (i.e., 200 mM). This effect was gradually reversed
as the concentration of NaHS was increased, with no sig-
nificant effect noted at concentrations in excess of 500mM
(Fig. 2A and B). In contrast, NaHS (0–1,000mM) did not
significantly affect LPS-evoked NO2
 formation, although a
trend toward activation of LPS-evoked NO2
 generation was
evident at higher concentrations. Interestingly, treatment of
RAW 264.7 cells with NaHS (100mM) did not increase the
concentration of H2S detected in the culture medium after
24 h (1.8 0.6 mM, c.f. 1.6 0.8 mM; n¼ 5; p> 0.05). Control
experiments showed that neither GYY4137 (1mM) nor NaHS
(1mM) induced a significant loss of cell viability (percentage)
assessed by using the MTT assay; GYY4137, 98.3 2.5%;
NaHS, 95.4 8.3%; vehicle-treated control cells, 102.9 3.2%
(all n¼ 5; p> 0.05).
Effect of GYY4137 and NaHS on LPS-evoked
cytokine formation
Treatment of RAW 264.7 cells with LPS also resulted in a
significant increase in both TNF-a and IL-1b concentrations in
the medium. Co-treatment of LPS-exposed RAW 264.7 cells
with GYY4137 (0–1,000 mM) resulted in a concentration-re-
lated inhibition of the formation of both TNF-a (Fig. 3A) and
IL-1b (Fig. 3B) with IC50 values of 70.4 4.4 and 134.1
10.1 mM (n¼ 5), respectively. In both cases, substantial inhi-
bition was achieved at higher concentrations of GYY4137
(>500mM). In contrast, NaHS (0–1,000mM) did not inhibit the
biosynthesis of either cytokine (Fig. 3A and B). Indeed, at the
highest concentration of NaHS used, a significant enhance-
ment of the LPS-evoked generation of both TNF-a and IL-1b.
Because GYY4137 elicited concentration-dependent inhi-
bition of LPS-induced TNF-a and IL-1b formation, we also
investigated the effect of this H2S donor on the generation of
both proinflammatory IL-6 and antiinflammatory IL-10 in
cultured RAW 264.7 cells under identical experimental con-
ditions. GYY4137 (10–500 mM) inhibited the LPS-evoked in-
crease in IL-6 concentration (Fig. 4A), while potentiating the
LPS-evoked increase in biosynthesis of IL-10 (Fig. 4B). Even
the lowest concentration of GYY4137 used (i.e., 10mM) re-
duced IL-6 formation by >50%. In comparison, NaHS
FIG. 1. Time course of in vitro enzymatic formation of H2S from l-cysteine by recombinant CSE and CBS (A) and
spontaneous H2S release from incubated NaHS (1 lM, B) and GYY4137 (100 lM, C). H2S was detected amperometrically.
Results show representative traces from at least four separate experiments.
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(100 mM) also inhibited IL-6 production but failed to affect the
generation of IL-10 (Fig. 4A and B).
Effect of GYY4137 on phosphorylation
of HSP 27 and ATF-2
Incubation of RAW 264.7 cells with LPS resulted in marked
phosphorylation of both HSP27 and ATF-2 (Fig. 5A and B). In
both cases, inclusion of GYY4137 (10–500 mM) significantly
inhibited LPS-evoked phosphorylation. GYY4137 was par-
ticularly effective as an inhibitor of HSP-27 phosphorylation
with an IC50 of 14.0 1.1 mM (n¼ 5). Similarly, relatively low
concentrations of GYY4137 (10–100 mM) also inhibited ATF-2
phosphorylation, with an IC50 of 35.1 6.7 mM (n¼ 5). How-
ever, in this case, inhibition declined and was partially re-
versed at the highest concentration (500 mM).
Effect of GYY4137 and NaHS on LPS-evoked
activation of NF-kB
Treatment of RAW 264.7 cells with LPS resulted in a
significant increase in NF-kB activation. Treatment of LPS-
exposed RAW 264.7 cells with GYY4137 (0–1,000 mM) caused
a concentration-related inhibition of the activation of NF-kB
(Fig. 5), with an IC50 value of 214.8 10.0 mM (n¼ 5). Inter-
estingly, the effect of NaHS (0–1,000mM) was biphasic, with
lower concentrations (100–200 mM) promoting NF-kB activa-
tion, whereas a high concentration (1,000 mM) caused inhibi-
tion (Fig. 6).
Discussion
The role of H2S as an inflammatory mediator is clearly
complex. The vast majority of studies carried out used simple
sulfide salts such as sodium hydrosulfide (NaHS) and so-
dium sulfide (Na2S), which generate H2S instantaneously in
aqueous solutions. Indeed, we show here, by using an H2S-
selective probe, that NaHS releases large amounts of H2S over
a period of a few seconds. Although undoubtedly useful in
that these salts are convenient and circumvent the necessity
for the somewhat more-complex preparation of authentic
H2S gas solutions, the manner in which cells and tissues are
FIG. 2. Effect of NaHS (black columns) andGYY4137 (open
columns) on LPS (1lg/ml)-evoked release of PGE2 (A) and
nitrite (B) in incubated (24 h) RAW 264.7 cells. Results show
concentration of PGE2 (ng=ml) or nitrite (micromolar) and are
expressed as mean SEM; n¼ 5; *p< 0.05 (c.f. LPS group);
þp< 0.05 (c.f. saline group); ANOVA plus post hoc Tukey test.
FIG. 3. Effect of NaHS (black columns) and GYY4137
(open columns) on LPS (1lg/ml)-evoked release of TNF-a
(A) and IL-1b (B) in incubated (24 h) RAW 264.7 cells. Re-
sults show concentration of each cytokine (ng=ml) and are
expressed as mean SE; n¼ 5; *p< 0.05 (c.f, LPS group);
þp< 0.05 (c.f. saline group); ANOVA plus post hoc Tukey test.
1150 WHITEMAN ET AL.
exposed to the gas via NaHS, Na2S, and H2S gas solutions is
unlikely to reflect accurately either the physiologic or the
pathophysiologic situation. Thus, these approaches generate
an instant ‘‘bolus’’ of H2S rather than release H2S in a slow and
sustainedmanner, as occurs enzymatically fromCSE and CBS
and as would be expected to occur in intact cells=tissues.
Therefore, we investigated whether the effects of bolus H2S
(generated by NaHS) or slow and sustained H2S release (via
GYY4137) elicited differential responsiveness to LPS in mu-
rine RAW264.7 macrophages. In contrast to NaHS, the pres-
ent data reveal a very much slower and sustained release of
H2S, again measured by using an H2S-selective probe, from
incubated GYY4137. The present study serves, (a) to highlight
important differences in the effect of these two H2S donors on
the inflammatory response of cultured macrophages to LPS,
and (b) to shed new light on the possible mechanism(s) un-
derlying the recently reported antiinflammatory effect of the
slow-releasing H2S donor GYY4137 in LPS-evoked endotoxic
shock in vivo (12).
GYY4137 consistently inhibited LPS-evoked formation of
PGE2,
NO (as measured by NO2
 accumulation), TNF-a, IL-
1b, IL-6, and consistently augmented LPS-induced formation
of IL-10 in cultured RAW 264.7 cells. In contrast, the effect of
NaHS was very much less consistent, with a biphasic (inhi-
bition at a concentration of 200mM; no action at higher con-
centrations) effect on LPS-induced PGE2 and NO2
 formation
and no statistically significant inhibitory effect on the evoked
biosynthesis of either TNF-a or IL-1b. Indeed, at the highest
concentration studied, NaHS actually promoted LPS-evoked
cytokine generation in these cells. Whether such an effect
might contribute to the reported proinflammatory effect of
this H2S donor (e.g., 9) is not yet clear.
Decomposed GYY4137 (left at room temperature for 5
days) did not affect LPS-induced biosynthesis of either PGE2
or NO2
, demonstrating that the effects of GYY4137 observed
in this study were largely due to released H2S. Furthermore,
GYY4137 caused a concentration-dependent inhibition of the
LPS-induced NF-kB activation in RAW 264.7 cells, together
FIG. 4. Effect of NaHS (black column) and GYY4137 (open
columns) on LPS (1 lg/ml)-evoked release of IL-6 (A) and
IL-10 (B) in incubated (24 h) RAW 264.7 cells. Saline-treated
control cells are shown by the grey column. Results show
concentration of cytokines (pg=ml) and are expressed as
mean SEM; n¼ 5–9; *p< 0.05 (c.f. LPS group); þp< 0.05 (c.f.
saline group); ANOVA plus post hoc Tukey test.
FIG. 5. Effect of GYY4137 on phosphorylation of ATF-2
(A) and HSP-27 (B) in LPS (1 lg/ml)-treated (24 h) RAW
264.7 cells. Saline-treated control cells are shown by the grey
column. Results show ratio of phosphorylated to nonpho-
sphorylated product and are expressed as mean SEM;
n¼ 5; *p< 0.05 (c.f. LPS group); þp< 0.05 (c.f. saline group);
ANOVA plus post hoc Tukey test.
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with a concentration-dependent reduction of the phosphor-
ylation of both ATF-2 and HSP-27. In contrast, the effects of
NaHS on NF-kB activation was biphasic, in that lower con-
centrations increased activation, but higher concentrations
were inhibitory (500 mM or greater). Neither GYY4137 nor
NaHS at the highest concentration used in this study
(1,000 mM) affected cell viability and thus the observed effect
of these H2S donors on macrophage inflammatory mediator
release are unlikely to be secondary to any toxic effect of H2S,
at least under the experimental conditions used in the present
work.
We previously reported that GYY4137 reduced LPS-
evoked hypotension and organ damage while reducing
plasma cytokine levels in the rat in vivo (12). The present data
confirm that GYY4137 inhibits LPS-induced release of in-
flammatorymediators (i.e., PGE2,
NO, TNF-a, and IL1b) from
macrophages in vitro and show for the first time that this H2S
donor increases the release of antiinflammatory IL-10 under
the same experimental conditions. The finding that GYY4137
also inhibited LPS-induced NF-kB activation is consistent
with previous reports in the literature suggesting an inhibi-
tory effect of H2S on transcription via NF-kB. For example,
H2S (derived from NaHS) inhibited NF-kB activation in LPS-
challenged RAW 264.7 macrophages maintained in culture
(16), whereas exposure of rats to gaseous H2S reduced brain
(cortical) NF-kBmRNA (5). TheH2S donor drug, S-diclofenac,
also reduced liver NF-kB activation in LPS-injected rats (11).
In addition, H2S reduced kidney NF-kB activation in a rat
model of renal ischemia=reperfusion injury (22). Other po-
tential H2S donors, such as the garlic constituent, dially-
sulfide, also inhibit NF-kB activation in primary cultures of
human articular chondrocytes (8) and in lung fibrosis induced
by bleomycin in rats (7).
In contrast, we show here that only a high concentration of
NaHS inhibits NF-kB activation. Indeed, at lower concentra-
tions of NaHS (e.g., 100 and 200 mM), a small but significant
activation of NF-kB is apparent. Interestingly, a similar acti-
vating effect of this H2S donor was reported in an interferon-g
(IFN-g)primed human monocytic cell line (U937), most
likely by rapid degradation of IkBa (31). It is paradoxic that
NaHS (1mM) inhibits NF-kB activation in RAW 264.7 cells
but promotes the LPS-evoked formation of TNF-a and IL-1b
without significantly altering PGE2 orNO2
 generation. These
data suggest that NaHS at such high concentrations may also
be able to affect the function of transcription factors other than
NF-kB. In this respect, we previously reported that adminis-
tration of the H2S donor, S-diclofenac, reduced liver AP-1
activation in LPS-injected rats. An identical effect also was
observed with the parent compound, diclofenac (11), which
would argue against a direct effect of H2S on AP-1. However,
other H2S donors, such as diallysulfide and diallytrisulfide,
have both been reported to increase the DNA-binding activity
of AP-1 in rat epithelial clone 9 cells (23). Certainly, the present
data suggest that the effect of NaHS on NF-kB activation
under these experimental conditions is biphasic, and further
experiments are required to determine whether high con-
centrations of NaHS are able to affect other transcription
factors in these cells.
To the best of our knowledge, no other reports exist of
the effect of H2S donors on either ATF-2 or HSP-27. As such,
both should now be considered as potential targets for
GYY4137=H2S. In this respect, HSP-27 was recently im-
plicated as a regulator of the increased expression of both
cyclooxygenase-2 (COX-2) and IL-6 in inflammatory cells
exposed to LPS (1), most probably by modulating NF-kB
signaling (20), whereas ATF-2 is a member of the ATF=cAMP-
response element–binding protein family, which play an
important role in the cellular stress response. Interestingly,
TNF-a is one of the major target genes for ATF-2 (24).
Growing evidence suggests that ATF-2 plays an important
role in the stress response, cell growth and differentiation, as
well as the immune response, and the finding that it is tar-
geted by GYY4137 is potentially of wider interest.
An important feature of the present study is the finding
that, although GYY4137 consistently reduced LPS-evoked
inflammatorymechanisms in RAW264.7 cells, the response to
NaHS was less consistent. It should perhaps be noted that
other authors have detected an effect of NaHS on LPS-evoked
inflammatory changes (e.g., NO2
 formation, iNOS expres-
sion, and NF-kB activation) in RAW 264.7 cells in culture (16).
The reason for the discrepancy between the two studies in not
clear. However, important differences exist in the experi-
mental conditions used. For example, we incubated cells with
either GYY4137 or NaHS concurrent with LPS for 24 h,
whereas in the previous study, macrophages were pre-
incubated with NaHS for 12 h before addition of LPS, and
further incubation for an additional 18 h. Bearing in mind the
transient stability of NaHS in culture medium, it is likely that
the time course of exposure of cells to NaHS will be a very
important factor in determining the effect of H2S on LPS-
induced inflammatory mediator release under these experi-
mental conditions. With this in mind, it is interesting that, in
the present experiments, H2S was detectable in the culture
medium at the end of the incubation period when macro-
phages were incubated with GYY4137 but not with an
equivalent concentration of NaHS.
We previously reported that GYY4137 releases H2S slowly
(i.e., over a period of several hours) in aqueous buffer and
produces a sustained increase in plasma H2S concentration in
FIG. 6. Effect of NaHS (black columns) and GYY4137
(open columns) on activation of NF-jB in LPS (1lg/ml)-
treated (24 h) RAW 264.7 cells. Results show relative light
units (RLU) and are expressed as mean SEM; n¼ 5;
*p< 0.05 (c.f. LPS group); þp< 0.05 (c.f. saline group); AN-
OVA plus post hoc Tukey test.
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the anesthetized rat after parenteral injection (13). When dis-
solved in water, H2S rapidly forms the hydrosulfide anion
(HS), which enters into an equilibriumwith Hþ to yield H2S.
Consequently, GYY4137 is best considered a ‘‘slow releasing’’
H2S donor. In contrast, release of H2S from NaHS is rapid.
Indeed, NaHS injection did not result in measurable increase
in plasma H2S in the anesthetized rat. Thus, NaHS is con-
sidered a ‘‘fast releasing’’ donor of this gas (13). With this in
mind, it is conceivable that RAW 264.7 cells were exposed to
very much higher concentrations of H2S but for a very much
shorter time in the presence of NaHS (c.f. GYY4137).
In conclusion, the effect of H2S on inflammatory mecha-
nisms in isolated macrophages seems to be dependent to a
large extent on the choice of H2S donor. It is known that dif-
ferent donors release H2S at different rates. It is likely that
both the absolute concentration of this gas and the time course
of its presence after provocation of an inflammatory response
by LPS, in this instance, are critical. Drugs that release small
amounts of H2S over an extended time appear to be more
effective than drugs that release larger amounts of the gas
over a shorter time. This should perhaps be borne in mind in
the search for novel H2S donors with potential antiin-
flammatory activity in the clinic. Furthermore, the antiin-
flammatory effect of GYY4137, which we previously
identified in intact rats, is likely to be dependent on inhibition
of transcription through the NF-kB pathway. The possibility
that GYY4137may also interfere with both ATF-2 andHSP-27
is an intriguing one and warrants further study.
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Abbreviations Used
ATF-2¼ activating transcription factor-2
CBS¼ cystathionine b synthetase
CSE¼ cystathionine g lyase
GYY4137¼morpholin-4-ium 4-methoxyphenyl
(morpholino) phosphinodithioate
H2S¼hydrogen sulfide
HSP-27¼heat-shock protein-27
IL-1b¼ interleukin-1 beta
LPS¼ lipopolysaccharide
MTT¼ 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide
NaHS¼ sodium hydrosulfide
NF-kB¼nuclear factor kB
NO¼nitric oxide
NO2
 ¼nitrite
PGE2¼prostaglandin E2
TNFa¼ tumor necrosis factor alpha
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